Clearstead Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6
| Closed | -$151 | – | 2077 |
|
|
2024
Q1 | $151 | Hold |
6
| – | – | ﹤0.01% | 1494 |
|
|
2023
Q4 | $149 | Sell |
6
-5
| -45% | -$124 | ﹤0.01% | 1488 |
|
|
2023
Q3 | $672 | Buy |
11
+5
| +83% | +$305 | ﹤0.01% | 1476 |
|
|
2023
Q2 | $566 | Hold |
6
| – | – | ﹤0.01% | 1292 |
|
|
2023
Q1 | $982 | Hold |
6
| – | – | ﹤0.01% | 1244 |
|
|
2022
Q4 | $2.15K | Hold |
6
| – | – | ﹤0.01% | 1080 |
|
|
2022
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 1112 |
|
|
2022
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 1143 |
|
|
2022
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 1248 |
|
|
2021
Q4 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 1143 |
|